Antigen processing and presentation by the class I major histocompatibility complex

被引:502
|
作者
York, IA
Rock, KL
机构
[1] Department of Lymphocyte Biology, Dana-Farber Cancer Institute, Boston, MA 02215
关键词
class I major histocompatibility complex; antigen processing; antigen presentation; cytotoxic T lymphocyte; antigenic peptide;
D O I
10.1146/annurev.immunol.14.1.369
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Major histocompatibility complex (MHC) class I molecules bind peptides derived from cellular proteins and display them for surveillance by the immune system. These peptide-binding molecules are composed of a heavy chain, containing an antigen-binding groove, which is tightly associated with a light chain (beta(2)-microglobulin). The majority of presented peptides are generated by degradation of proteins in the cytoplasm, in many cases by a large multicatalytic proteolytic particle, the proteasome. Two beta-subunits of the proteasome, LMP2 and LMP7, are inducible by interferon-gamma and alter the catalytic activities of this particle, enhancing the presentation of at least some antigens. After production of the peptide in the cytosol, it is transported across the endoplasmic reticulum (ER) membrane in an ATP-dependent manner by TAP (transporter associated with antigen presentation), a member of the ATP-binding cassette family of transport proteins. There are minor pathways for generating presented peptides directly in the ER, and some evidence suggests that peptides may be further trimmed in this location. The class I heavy chain and beta(2)-microglobulin are cotranslationally translocated into the endoplasmic reticulum where their assembly may be facilitated by the sequential association of the heavy chain with chaperone proteins BiP and calnexin. The class I molecule then associates with the lumenal face of TAP where it is retained, presumably awaiting a peptide. After the class I molecule binds a peptide, it is released for exocytosis to the cell surface where cytotoxic T lymphocytes examine it for peptides derived from foreign proteins.
引用
收藏
页码:369 / 396
页数:28
相关论文
共 50 条
  • [1] Major histocompatibility complex class I-restricted antigen processing and presentation
    Van Kaer, L
    TISSUE ANTIGENS, 2002, 60 (01): : 1 - 9
  • [2] Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation
    Yang, Y
    Sempe, P
    Peterson, PA
    IMMUNOLOGIC RESEARCH, 1996, 15 (03) : 208 - 233
  • [3] Post-proteasomal antigen processing for major histocompatibility complex class I presentation
    Rock, KL
    York, IA
    Goldberg, AL
    NATURE IMMUNOLOGY, 2004, 5 (07) : 670 - 677
  • [4] Peptide generation in the major histocompatibility complex class I antigen processing and presentation pathway
    Androlewicz, MJ
    CURRENT OPINION IN HEMATOLOGY, 2001, 8 (01) : 12 - 16
  • [5] Post-proteasomal antigen processing for major histocompatibility complex class I presentation
    Kenneth L Rock
    Ian A York
    Alfred L Goldberg
    Nature Immunology, 2004, 5 : 670 - 677
  • [6] Proteolysis and class I major histocompatibility complex antigen presentation
    York, IA
    Goldberg, AL
    Mo, XY
    Rock, KL
    IMMUNOLOGICAL REVIEWS, 1999, 172 : 49 - 66
  • [7] Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes
    Hung, CF
    Cheng, WF
    He, LM
    Ling, M
    Juang, J
    Lin, CT
    Wu, TC
    CANCER RESEARCH, 2003, 63 (10) : 2393 - 2398
  • [8] Thiol oxidation and reduction in major histocompatibility complex class I-restricted antigen processing and presentation
    Dick, TP
    Cresswell, P
    PROTEIN SENSORS AND REACTIVE OXYGEN SPECIES, PT B, THIOL ENZYMES AND PROTEINS, 2002, 348 : 49 - 54
  • [9] PRESENTATION OF AN EXOGENOUS ANTIGEN BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES
    ULMER, JB
    DONNELLY, JJ
    LIU, MA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (07) : 1590 - 1596
  • [10] ANTIGEN PRESENTATION BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-B MOLECULES
    SHAWAR, SM
    VYAS, JM
    RODGERS, JR
    RICH, RR
    ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 839 - 880